It is known that chronic ethanol (EtOH) consumption leads to hypertension development and has been associated with deleterious effects on the cardiovascular system. Whether this condition alters calcium (Ca   2+   ) signaling and exocytosis in adrenal chromaffin cells (CCs) as the case is for genetic hypertension, is unknown. We explored this question in four randomized experimental groups, male Wistar Kyoto (WKY/EtOH) and Spontaneously Hypertensive (SHR/EtOH) rats were subjected to the intake of increasing EtOH concentrations 
Introduction
Chronic ethanol (EtOH) consumption increases by 75% the probability of developing hypertension; it is estimated that around 5-24% cases of arterial hypertension are associated to chronic EtOH drinking, which causes 10.000 deaths only in the USA (Briasoulis et al., 2012; Li et al., 2004) . In the rat, the elevation of blood pressure is already apparent after a week of EtOH drinking and is maintained elevated throughout the entire period of EtOH exposure (Marchi et al., 2016 (Marchi et al., , 2014 Passaglia et al., 2015; Crestani et al., 2014; Da Silva et al., 2013; Tirapelli et al., 2008b Tirapelli et al., , 2008a . Such elevation has been associated with increased vascular reactivity due to enhanced concentrations of cytosolic calcium (Ca 2+ ) ([Ca 2+ ] c ), altered ionic currents, or pronounced oxidative stress with concomitant endothelial dysfunction; all these changes may ultimately be triggered by an augmented activity of the sympathoadrenal axis (Marchi et al., 2014; Husain et al., 2014) .
Increased sympathetic activity seems to be a major contributing factor in the pathogenesis of human essential hypertension (Goldstein, 1983; de Champlain et al., 1976) as well as in the spontaneously hypertensive rat (SHR). This has been supported by direct recording of sympathetic nerve activity in humans (Esler, 2015; Anderson et al., 1989) and SHR (Morrison and Whitehorn, 1984) as well as by indirect monitoring of the circulating levels of catecholamines that are elevated both in hypertensive humans (Goldstein, 1983; de Champlain et al., 1976) and in SHR (Tsunoda et al., 2000) . Because the plasma catecholamine noradrenaline mainly comes from sympathetic nerves and adrenaline from adrenal medullary chromaffin cells (CCs) (Arnaiz et al., 1978) , it was predicted that the adrenal catecholamine release should be enhanced in SHR with respect to normotensive genetic counterpart Wistar Kyoto Rat (WKY). This was first demonstrated to be http://dx.doi.org/10.1016/j.ejphar.2017.03.017 Received 10 October 2016; Received in revised form 7 March 2017; Accepted 13 March 2017 the case in perfused adrenal glands (Lim et al., 2002) and later on primary CCs cultures (Segura-Chama et al., 2015) .
Whit this background in mind, we here raised the hypothesis that the elevation of the systolic blood pressure (SBP) elicited by chronic EtOH exposure of WKY rats, could also be associated with an augmented catecholamine release from their CCs. To test this hypothesis we designed the present parallel study in four groups of rats namely, WKY drinking water (WKY/Control), WKY drinking EtOH in water (WKY/EtOH), SHR drinking water (SHR/Control) and SHR drinking EtOH in water (SHR/EtOH). In CCs of the four groups we have monitored the quantal release of catecholamine, the resting membrane potential (Vm), firing of spontaneous action potentials (SAPs), the inward whole-cell Ca 2+ current (I ca ), the outward K + current (I K ), and the [Ca 2+ ] c transients. We have also measured some cardiovascular and blood parameters. We have corroborated that chronic EtOH consumption by WKY rats certainly caused a raise of SBP. We demonstrate for the first time that such elevation is accompanied by a drastic augmentation of the quantal catecholamine release from CCs. Such augmentation was equivalent to that occurring in SHR rats, either with or without EtOH exposure.
Material and methods

Animals and treatments
All procedures employed in this study were conducted according to the guidelines of the Brazilian Association for Accreditation of Laboratory Animal Care (11.794/2008) Experiments were carried out in male adult (330 ± 20 g) normotensive Wistar Kyoto (WKY) and SHR rats 14-16 weeks old, obtained from Charles River Laboratories (Wilmington, Massachusetts, USA) that have been housed in our animal facilities (UAM and/or UNIFESP). After 3-6 days of habituation with standard chow and water ad libitum, controlled temperature (22 ± 1°C) and relative humidity (60%) with 12 h dark/light cycle, rats were randomly assigned to four experimental groups namely, two control groups drinking water (WKY/ Control and SHR/Control) and two experimental groups drinking EtOH in water (v/v) as follows: 5% in the first week, 10% in the second week, and 20% in the third and fourth weeks (Marchi et al., 2016 (Marchi et al., , 2014 Passaglia et al., 2015; Crestani et al., 2014; Da Silva et al., 2013; Resstel et al., 2008; Tirapelli et al., 2008b Tirapelli et al., , 2008a Chan and Sutter, 1983) . These previous studies demonstrated that chronic EtOH consumption induces a progressive increase in SBP from the first week of treatment and is maintained throughout the period.
Heart weight and systolic blood pressure
Heart weight was estimated with a digital scale and expressed as the ratio of the heart/body weight after the end of chronic EtOH treatment and values represent the mean obtained for each experimental group. We measured SBP by non-invasive tail-cuff plethysmography in nonanesthetized rats (Cibertec S.A, Madrid, Spain and/or IITC Inc, Ithaca, CA, USA) as previously described (Musial et al., 2015; Plehm et al., 2006) .
Plasma EtOH concentration, H 2 O 2 production, and ALDH activity
At the end of chronic treatments animals were killed by decapitation and around 2.5 ml of blood samples were removed from the heart cavity with heparinized syringes and tubes. The plasma was separated by centrifugation (12 min, 3000 rpm, 3-5°C) and stored at −80°C until the moment of analysis. 
Primary culture of chromaffin cells from WKY and SHR rats
The primary culture of adrenal CCs was performed as previously described (Calvo-Gallardo et al., 2015) . Adrenal glands were rapidly removed from decapitated rats, placed in ice-cold Locke´s solution with the following composition (in mM): 154 NaCl, 5.5 KCl, 3.6 NaHCO 3 , 10 HEPES, and 5.5 D-glucose, pH 7.4 adjusted with NaOH. Glands were fat trimmed, and medullae were isolated by removing the cortex. Then, the medullae were placed in a tube containing 200 µl Locke's solution with papain (25 U/ml) for tissue digestion during 30 min at 37°C. This solution was exchanged by 1 ml Dulbecco´s modified Eagles medium (DMEM), repeating the exchange three times and leaving finally 120 µl of DMEM. Then, medullae were carefully minced first with a 1 ml micropipette and then with a 200 µl micropipette. Finally, the residual medulla fragments were discarded and 10-20 µl drops of cell containing solution from the minced extracts were plated on poly-D-lysine-coated coverslips of one or two 12-well plates. After 30 min in an incubator (37°C, water saturated, and 5% CO 2 atmosphere) 1 ml DMEM supplemented with 4% fetal bovine serum, 50 IU/ml penicillin, and 50 µg/ml streptomycin were added to each well; cells were used 1-2 days thereafter.
Recording of whole cell currents through calcium and potassium channels
The perforated-patch mode of the patch-clamp technique was used to record whole cell I Ca using amphotericin B (50 µg/ml) as permeating agent (Rae et al., 1991) . Coverslips containing the cells were placed on an experimental chamber mounted on the stage of a Nikon Diaphot inverted microscope (Nikon Co., Tokyo, Japan). Tight seals ( > 5 GΩ) were achieved and cells were continuously superfused with an extracellular Tyrode solution composed of the following (in mM): 137 NaCl, 1 MgCl 2 , 5 CaCl 2 , 5.3 KCl, 10 glucose, and 10 HEPES; 1 µM tetrodotoxin was added to block sodium currents. The intracellular solution had the following composition (in mM): 145 CsCl, 9 NaCl, 1 MgCl 2 , 10 HEPES, pH 7.3.
I Ca recordings were made with firepolished borosilicate pipettes (Narishige PC-10 pipette; Narishige, Tokyo, Japan), with resistance of 3-5 MΩ at room temperature (22-25°C) using an EPC-10 patchclamp amplifier (HEKA Elektronik, Lambrecht, Germany), allowing cancellation of capacitative transients and compensation of series resistance. The extracellular solutions were rapidly exchanged using electronically driven miniature solenoid valves coupled to a multibarrel concentration clamp device, the common outlet of which was placed within 100 µm of the cell to be patched. The flow rate was 1 ml/min and was regulated by gravity. Data were acquired with a sample frequency of 20 kHz by using PULSE 8.74 software (HEKA Elektronik, Lambrecht, Germany) and analysis was performed with Igor Pro 4.08 (Wavemetrics, Lake Oswego, OR).
The access resistance (R s ) was monitored until it decreased to < 15 MΩ. In all recordings, the holding potential was −80 mV. Inward current-voltage (I-V) curves for I Ca were obtained by applying 50-ms depolarizing test pulses from −60 to 60 mV at 10 mV steps and 10-s intervals (protocol illustration on center of Fig. 1 ). The I Ca peak was obtained in response to 50-ms depolarizing pulses to −10 mV and 0 mV (protocol illustration on top of panel A , Fig. 2) ; all signals were filtered at 5 kHz, digitized at 50 kHz, and on-line leak subtracted. I Ca (Late) and the time constant for current decay (τ i ) are indicators of the degree of inactivation of I Ca and were calculated in each individual current trace.
For measuring outward voltage-dependent K + currents [I K(V) ], the intracellular solution had the following composition (in mM): 140 KCl, 10 NaCl, 1 MgCl 2 , 10 HEPES, pH 7.3 with an extracellular Tyrode solution, under perforated-patch configuration. I-V curves were obtained by applying 100-ms depolarizing test pulses from −30 to 110 mV applied in 10 mV steps at 10-s intervals (protocol illustration on center of Fig. 3 ). I K(Ca) were unmasked by applying a 10-ms depolarizing pre-pulse to −30 mV to inject Ca 2+ into the CCs cytosol through voltage-gated Ca 2+ channels (Ca v s) followed by a pulse to 120 mV to generate I K (protocol illustration on center of panels D-E, Fig. 4 ). With this protocol, the different components of I K are revealed and the I K(Ca) component was confirmed by application of 1 µM paxilline, an alkaloid that selectively inhibits large conductance Ca 2+ -activated potassium channels (added 60 s before of the pulse).
Monitoring of cell excitability
Using the current-clamp mode (current injection was set at 0 pA) in the perforated-patch configuration, the resting membrane potential (V m ), and spontaneous action potentials (SAPs) were recorded during 240 s. The CCs were superfused with standard extracellular solution and the intracellular solution used to record the potassium currents. The SAPs amplitude was defined as the difference between the peak and the initial V m recorded ± 50 ms prior to the peak. When a cell presented erratic basal membrane potential fluctuations of ≤5 mV, they were discarded. Resting V m was defined as the average of the values recorded during the 240 s recording period.
Measurements of cytosolic Ca 2+ concentrations
To measure the [Ca 2+ ] c , CCs were incubated for 1 h at 37°C in DMEM medium containing the Ca 2+ probe fura-2 AM (10 µM).
Thereafter, coverslips were mounted in a chamber; CCs were washed and covered with Tyrode solution containing 2 mM Ca
2+
. The setup for fluorescence recordings was composed of a Leica DMI 4000 B inverted light microscope (Leica Microsystems, Barcelona, Spain) equipped with an oil immersion objective (Leica 40 x Plan Apo; numerical aperture 1.25). Once CCs were placed on the microscope, they were continuously superfused by means of a five way superfusion system at 1 ml/ min with a common outlet 0.28 mm tube, driven by electrically controlled valves with Tyrode solution. Fura-2 AM was excited alternatively at 340 ± 10 and 380 ± 10 nm using a Küber CODIX xenon arc lamp (Leica Microsystems, Barcelona, Spain). Emitted fluorescence was collected through a 500 ± 40 nm emission filter and measured with an intensified charge coupled device camera (Hamamatsu C10600 orca R 2 , Hamamatsu, Japan). Fluorescence images were generated at 1-s intervals. All experiments were performed at room temperature (24 ± 2°C) on CCs from 1 to 2 days after CCs culture (Padín et al., 2012 (Chow et al., 1992) and carbon fiber microelectrodes were built as previously described (Calvo-Gallardo et al., 2015). Briefly, a carbon # fiber of 10 µm in diameter was insulated with polypropylene and connected to the amplifier. Electrodes were calibrated by exposing the tip to 50 µM adrenaline (insensitive electrodes with amperometric current < 200 pA were discarded). The coverslips were mounted in a chamber on a Nikon Diaphot inverted microscope (Nikon, Tokyo, Japan). To monitor catecholamine release, the microelectrode was placed close to the CCs surface with a high-precision micromanipulator and maintained at a potential of +700 mV against an Ag/AgCl bath reference electrode. Recordings were performed with an EPC-10 amplifier under voltage-clamp mode, using the Pulse v8.74 software (HEKA Electronic, Lambrecht, Germany). Current data was acquired at 10 kHz, and catecholamine release from CCs was elicited by highpotassium stimulus (K + 75 mM, for 60 s).
Data analysis and statistics
The data of cardiovascular parameters, oxidative metabolism of EtOH, ionic currents, and cell excitability were analyzed using the software Graph Pad Prism version 5.1 (Inc., La Jolla, California, U.S.A.) and Igor Pro version 4.08 (Wavemetrics, Lake Oswego, OR). Data on [Ca 2+ ] c measurements were obtained using LAS AF software version 2.4.2. (Leica Microsystems, Barcelona, Spain). All graphs and the mathematical analyses were performed using the Graph Pad Prism version 5.1. The peaks and areas were calculated by integrating the [Ca 2+ ] c transients versus time during the stimulus duration by means of Origin Pro 8 software version 8.08 (Northampton, Massachusetts, USA). Data represent the mean ± S.E.M. of the number of CCs and cultures shown in parentheses (n, N). One-way ANOVA followed by Bonferroni's multiple comparison post-hoc test was used to determine statistical significance between means. The limit of significance was accepted when *P < 0. 
Results
Cardiovascular and blood parameters
The cardiovascular and blood parameters monitored at the end of EtOH exposure are summarized in Table 1 . Mean baseline heart weight normalized with respect to body weight, was 3.7 g in WKY/Control and 5.0 g in SHR/Control. EtOH exposure elicited a significant 35.3% heart weight increase in WKY rats, and no significant change in SHR. Baseline mean SBP was 135.8 mmHg in WKY/Control and 218.5 mmHg in SHR/Control. EtOH exposure elicited a significant 10.6% increase in WKY/EtOH and a significant 6.1% increase in SHR/ EtOH. In absolute terms these changes were similar for WKY/EtOH and SHR/EtOH, about 15 mmHg. This contrasts with relative changes in heart weight in WKY/EtOH that were much more pronounced (35.3% with respect to WKY/Control) than those undergone by SHR/ EtOH (5.2% with respect to SHR/Control).
The mean circulating levels of EtOH accounted by 6.98 nmol/ml in WKY/EtOH and 18.0 nmol/ml in SHR/EtOH, 2.5-fold higher. This was opposite to the plasma levels of ALDH activity that at baseline were close: 11.1 and 15.0 mU/ml for WKY/Control and SHR/Control, N) . The results were analyzed by one-way ANOVA followed by Bonferroni's multiple comparison post-hoc test. Significance was accepted at *P < 0.05 vs. I Ca (peak) of respective group; τ P < 0.05 vs. I Ca (late) of WKY/Control group; @ P < 0.05 vs. I Ca (peak) of WKY/Control group; n.s., non-significant.
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Whole-cell inward calcium currents
Primary cultures of CCs were prepared from adrenal glands taken from rats of all experimental groups at the end of the different treatments. CCs were voltage-clamped at −80 mV and perfused with a standard extracellular solution containing 5 mM Ca 2+ to increase I Ca amplitude and to favor its Ca 2+ -dependent inactivation (HernandezGuijo et al., 2001) . Inward I Ca were generated by applying repeated 50-ms depolarizing test pulses to different voltages, under the perforatedpatch mode of the patch-clamp technique. This permitted the recording of current families along several minutes, with fairly reproducible I Ca traces.
For instance, the families of I Ca traces represented in Fig. 1A were obtained from a WKY/Control CC through the application of a series of test pulses given at 10-s intervals in 10-mV steps, from −60 to 60 mV. A similar family of I Ca currents generated in a WKY/EtOH CC is displayed in Fig. 1B . It appears that current amplitudes are lower and undergo lesser current inactivation in the WKY/EtOH CCs, compared with the WKY/Control CCs. Averaged current-voltage relationship (I-V curves) indicates that in WKY/Control the threshold I Ca was at −30 mV, peaked at −10 mV, and exhibited its reversal potential at −50 mV. These parameters were similar in the averaged WKY/EtOH, indicating that no shifts among the two I-V curves occurred. However, averaged current amplitudes were significantly lower at practically all voltages tested; specifically, peak current at −10 mV was 39.0 ± 12.9% smaller in SHR/control, with respect to WKY/Control CCs (Fig. 1C) .
A family of I Ca traces obtained at the various test-voltages in a SHR/control CC is shown in Fig. 1D ; peak currents are apparently smaller than those shown in Fig. 1A for WKY/control. The family of I Ca traces obtained from a SHR/EtOH CC (Fig. 1E) shows further decrease of current amplitude, if compared with the SHR/control (panel D). The averaged I-V curve from SHR/Control shows a threshold current at −30 to −20 mV, peaked at 0 mV, and exhibited a reversal potential at −50 mV. The I-V curve plotted with data averaged from SHR/EtOH had no shifts with respect to the SHR/control, but exhibited significant smaller I Ca peak amplitudes at several voltages (i.e. 30.2% smaller at 0 mV) (Fig. 1F) .
Another interesting differential feature concerned I Ca kinetics. For instance, in the current families of example WKY/control and WKY/ EtOH CCs, the current inactivation is less pronounced in the latter (Fig. 1B) as compared with the former (Fig. 1A) . Even lesser current inactivation occurred in the I Ca traces of the SHR/control CCs (Fig. 1D) ; practically no inactivation was apparent in the SHR/EtOH CCs (Fig. 1E ). These differences are better illustrated in the example I Ca traces generated by test pulses at 0 mV in which peak currents occurred ( Fig. 2A-D) . Note the pronounced current inactivation of the WKY/ Control I Ca trace ( Fig. 2A) , the lesser inactivation of the WKY/EtOH trace (Fig. 2B) , and the practically nil inactivation of the SHR/control trace (Fig. 2C) and SHR/EtOH trace (Fig. 2D) . This is better illustrated in the bar graphs of Fig. 2E showing the greatest peak current of WKY/ control CCs (246.7 ± 22.0 pA) having obviously the smallest late I Ca amplitude (129.2 ± 7.4 pA) which represents a reduction of 47.2%. On the other hand, in WKY/EtOH, SHR/Control, and SHR/EtOH CCs the reduction was about 11.5%, 1.7% and 4.8%, respectively. These differences were better seen when time constants for current decay (τ i ) were plotted (Fig. 2F) . The τ i for I Ca inactivation was 1.3 ± 0.2 ms in WKY/Control,85.2% higher in WKY/EtOH CCs, 91.8% higher in SHR/ control CCs, and 61.3% higher in SHR/EtOH CCs, indicating a substantially slower current inactivation in CCs from EtOH-treated rats and from hypertensive rats. It seems therefore reasonable to bring about the conclusion that chronic EtOH consumption and high blood pressure decrease I Ca amplitude and delay I Ca inactivation in CCs.
Whole-cell voltage-dependent outward potassium currents
Next we investigated the effects of chronic EtOH consumption on the voltage-dependent outward potassium currents (I K(V) ) in CCs from all experimental groups. Cells were voltage-clamped at −80 mV and 100-ms test pulses were sequentially applied from −30 to 110 mV in 10-mV steps at 10-s intervals (protocol on center left of Fig. 3) . A family of I K(V) original traces recorded in a WKY/control CCis displayed in Fig. 3A . At the lower voltages, there was some inactivation likely due to Ca Data represent the mean ± SEM of the number of animals shown in parentheses (n). Heart weight is normalized to rat weight. The results were analyzed by one-way ANOVA followed by Bonferroni's multiple comparison post-hoc test; significance was accepted at: a P < 0.05 vs. WKY/Control group. b P < 0.05 vs. SHR/Control group. c P < 0.05 vs. WKY/EtOH group; n.s., non-significant, n.d., non-detectable.
cell K + current does not undergo inactivation and is entirely due to
. Panel B shows a family of I K(V) generated in a WKY/EtOH CC that presents a clear diminution of peak current amplitude with respect to the WKY/control. The current family of panel D belongs to a SHR/ control CC that also exhibits a smaller I K(V) peak with respect to the WKY/control. And finally, the I K(V) traces of panel E are from a SHR/ EtOH CC that exhibited smaller peak current amplitudes with respect to both WKY/control and SHR/control CCs. On quantitative terms, it is worth noting the substantial reduction of I K(V) peak amplitude from 3087.2 ± 179.2 pA in untreated WKY/ Control to 1871.2 ± 279.5 pA in WKYs chronically exposed to EtOH. Such reduction was observed at practically all voltages (Fig. 3C) . Peak I K(V) was further reduced in CCs from SHR/Control rats (1849.3 ± 70.4 pA); at the higher test voltages (90-110 mV), chronic EtOH in SHRs produced a further I K(V) reduction of around 23.5% with respect to SHR/Control (Fig. 3F) . In summary, both hypertension and chronic EtOH caused a reduction of I K(V) with respect to WKY/Control CCs; this reduction was even higher in SHR/EtOH CCs.
Calcium-dependent potassium currents
The calcium-dependent component of the whole-cell outward potassium current (I K(Ca) ) is salient in adrenal CCs (Marty, 1981) ; thus, it seemed of interest to explore the effects of chronic EtOH consumption on I K(Ca) . The protocol to unmask the I K(Ca) component in the whole-cell I K included a 10-ms depolarizing prepulse to −30 mV to inject Ca 2+ inside the cell through Ca v s, followed by a 100-ms test pulse to 120 mV to generate a full I K (protocol on center of (Fig. 4A) . Averaged data of I K(Ca) amplitudes are plotted in panels C and F. Chronic EtOH reduced I K(Ca) from 1688.6 ± 97.1 pA in WKY/Control CCs to 963.2 ± 182.7 pA in WKY/EtOH CCs. Paxilline reduced I K(Ca) by 80.1% in both cell types; such blockade was reversible upon paxilline washout (Fig. 4C) . In SHR/Control, I K(Ca) was 884.7 ± 138.6 pA, about half that of WKY/ Control. Similar data were found in SHR/EtOH CCs (1105.7 ± 80.4 pA). Once more, paxilline reversibly blocked the current (Fig. 4F) . In summary, chronic EtOH consumption and hypertension itself, caused a pronounced reduction of I K(Ca) ; however, EtOH did not further reduce the already diminished I K(Ca) in SHRs.
Resting membrane potential and spontaneous action potentials
It is known that rat CCs discharge SAPs and thus, we felt thoughtful to inquire about how chronic EtOH consumption could affect the resting membrane potential and the SAPs frequency in CCs from all experimental groups (de Diego et al., 2008) . To this aim, the currentclamp mode of the patch-clamp technique was used. Fig. 5A shows an original trace of the spontaneous electrical activity in a WKY/Control CC. Its initial V m was −56.1 ± 1.1 mV and the cell fired SAPs at irregular intervals, faster at the beginning and later on at a slower rate, to disappear at the end of the trace, a kind of adaptation (Yarom et al., 1985) . The record of panel B was from a WKY/EtOH CC that exhibited somehow a higher rate of SAPs with no apparent adaptation. The firing pattern of SAPs also exhibited higher frequency and larger amplitudes in the example SHR/Control CC (panel C) and the example SHR/EtOH CC, which also exhibited adaptation (panel D). Averaged V m values are plotted in Fig. 5E ; they were −56.1 ± 1.1 mV for WKY/ Control CCs, 11.5% less negative for WKY/EtOH (−49.6 ± 1.4 mV) and 10.6% less negative for SHR/Control (−50.1 ± 1.3 mV). In SHR/EtOH, V m did not significantly change with respect to WKY/control. Not all cells discharged SAPs; thus, 67.6% of WKY/Control, 76.9% of WKY/EtOH, 80.1% of SHR/Control, and 86.3% of SHR/EtOH exhibited firing activity. The rates of SAP firing (number of SAPs per recording period of 240 s) were 34.6 ± 3.7 for WKY/Control, 56.4 ± 5.0 for WKY/EtOH, 62.7 ± 10.6 for SHR/control, and 75.5 ± 12.7 for SHR/ EtOH. In summary, EtOH exposure caused a depolarization of CCs and an increased rate of firing of SAPs.
Elevations of cytosolic calcium concentrations triggered by potassium-elicited depolarization of chromaffin cells
Altered ion currents and cell excitability could likely lead to altered [Ca 2+ ] c changes in CCs from rats chronically treated with EtOH. This hypothesis was tested in CCs loaded with fura-2 and depolarized by high K + (75 mM, 60 s); at this concentration, K + drives the V m of CCs to 0 mV (Orozco et al., 2006) . Under these experimental conditions, the [Ca 2+ ] c signal of CCs is the result of complex regulatory mechanisms involving Ca 2+ entry through Ca v s followed by its redistribution into organelles, essentially the endoplasmic reticulum (ER) and mitochondria (Garcia et al., , 2012 ] had a F 340 /F 380 fluorescence ratio of 0.24 ± 0.02 while in 36 WKY/EtOH cells it was 0.38 ± 0.03 (48.1% higher) (Fig. 6C) . A similar increase was observed in the areas expressed as arbitrary fluorescence units per minute namely, 19.65 ± 2.66 and 31.34 ± 3.11 AFU.min in WKY/Control and WKY/EtOH, respectively (Fig. 6D) . In SHR CCs the K + -elicited [Ca 2+ ] c transients were higher, as shown in the 2 example SHR/Control and SHR/EtOH CCs records displayed in Fig. 6B . Pooled data from 32 SHR/Control cells, showed peak fluorescence ratios of 0.51 ± 0.03 and in 35 SHR/EtOH cells it was 0.59 ± 0.05 (Fig. 6C) . The values for the areas were 42.37 ± 2.52 and 44.14 ± 2.56 AFU.min, respectively for SHR/Control and SHR/ EtOH CCs.
Quantal catecholamine release responses triggered by high potassium in chromaffin cells
To study the quantal release of catecholamines, all experiments began with an initial 120 s perfusion resting period with a standard Tyrode solution for adaptation of the targeted CC to its environment. To stimulate exocytosis, CCs were depolarized with high K + (75 mM, 60 s). Pooled data on cumulative secretion vs. time calculated at 5-s intervals from experiments similar to those shown in the example records of Fig. 7A -D, were plotted in panel E. In CCs from all experimental groups, an initial faster rate of secretion during the first 10-s of the high-K + pulse was observed. However, in CCs from WKY/ EtOH and SHR/Control rats, a high rate of secretion which remained along the next 50-s period, was observed. The integrated secretion (area in pC of all spikes secreted by each high-K + pulse) is plotted in panel F; this total secretion was 2.1-fold higher in WKY/EtOH CCs, 2.3-fold higher in SHR/Control and 2-fold higher in SHR/EtOH CCs, with respect to WKY/Control (32.2 ± 3.1 pC). Additionally, the total number of spikes per high-K + stimulus was shown to follow the same pattern (panel G); they were 1.8-fold, 2.4-fold and 2.2-fold higher in WKY/EtOH, SHR/Control and SHR/EtOH, respectively, with respect to WKY/Control CCs (43.2 ± 3.5 spike number). In summary, it seems that chronic EtOH consumption causes a sharp increase of the total secretion and spike numbers in normotensive rats, and did not change the secretion in SHR-EtOH CCs which already had greater quantal secretion. Spike frequency histograms counted at 5-s intervals during the 60-s stimulation periods are shown in panels H and I. The chronic EtOH consumption in WKY CCs produced an increase in the plateau of 4.1-fold with respect to WKY/Control (0.9 ± 0.4). In SHR/EtOH CCs, the increase in the plateau was 1.8-fold. The decay of the rate of spike frequency was best fitted to a single exponential curve, as described in panel J. The time constant for inactivation (τ i ) of spike frequency was 8.2 ± 0.5 s in WKY/Control CCs while it was 1.3-fold higher in WKY/ EtOH, 3.1-fold higher SHR/control, and 2.3-fold higher in SHR/EtOH, N) . The results were analyzed by one-way ANOVA followed by Bonferroni's multiple comparison post-hoc test. Significance was accepted at *P < 0.05 vs. WKY/Control group; n.s., non-significant.
indicating a substantially slower spike inactivation in CCs from EtOHtreated rats and from hypertensive rats.
Discussion
Two main findings are central stage in this investigation: (1) exposure of WKY normotensive rats to EtOH in drinking water for a month raises the SBP; (2) such an effect is accompanied by a drastic increase of the quantal release of catecholamine from adrenal CCs. The fact EtOH exposure leads to an increase in blood pressure has been documented for years, both in humans (Fernández-Solà, 2015; Klatsky, 2015; Li et al., 2004) and rats (Marchi et al., 2016 (Marchi et al., , 2014 Passaglia et al., 2015; Crestani et al., 2014; Da Silva et al., 2013; Resstel et al., 2008; Tirapelli et al., 2008b; Chan and Sutter, 1983) . However, as far as we know, the drastic augmentation of catecholamine release in CCs from WKY rats exposed to EtOH is reported for the first time in our present study. This finding agrees with the concept that elevated sympathoadrenal activity is implicated in the development of hypertension.
"Metabolic diseases, such as essential hypertension, are a cluster of metabolic and cardiovascular modifications involving multiple systems (Mendizábal et al., 2013) . Clinical, epidemiologic and experimental studies showed that the cellular mechanisms involved in EtOHtriggered hypertension are complex, multifactorial and has idiopathic causes (Marchi et al., 2016; Fernández-Solà, 2015; Husain et al., 2014) . With this background, although we postulated that the elevation of the SBP elicited by chronic EtOH exposure could be associated with alterations in electrophysiological properties and an augmented catecholamine release from their CCs, others systems and effects of EtOH consumption affect blood pressure. For example, changes in cardiac output and peripheral vascular resistance triggered by local mechanisms (autoregulation, metabolites and endothelial dysfunction) hormones (angiotensin, vasopressin, etc.) and neural mechanisms (sympathetic outflow, sensory nerves and renin-angiotensin-aldosterone system) contribute to increase of blood pressure during hypertensive state (Marchi et al., 2016; Fernández-Solà, 2015; Husain et al., 2014; Mendizábal et al., 2013) .
Through the recording of single amperometric secretory events in isolated CCs, we consistently found that in adult SHR rats with established hypertension that the catecholamine release responses triggered by K + depolarization were drastically elevated; furthermore, the quantal size of single exocytotic events was also augmented (Segura-Chama et al., 2015) . In the present study we found that WKY/EtOH rats also exhibited a drastic increase of catecholamine release monitored as spike number and quantal content; astonishingly, this elevation was similar to that found in SHR rats, either exposed or not to EtOH (Fig. 7) . The overactivity of the sympathoadrenal axis can be measured by direct stimulus of sympathetic nerve terminals or by indirect method that is based on heart rate or plasma catecholamines levels. Although there are some limitations, the plasma measurement of catecholamines levels is a common and traditional approach for assessing sympathetic overdrive (Grassi et al., 2015) . In previous studies, both experimental models and patients with borderline or established essential hypertension showed an elevation in plasma catecholamines levels (Maciorkowska et al., 2015; Masuo et al., 2003; Jablonskis and Howe, 1994; Goldstein, 1983; de Champlain et al., 1976) .
Several researchers have been demonstrated that different treatments with EtOH (including the same chronic EtOH treatment used in this study) increased plasma levels of catecholamines (Zhao et al., 2015; Da Silva et al., 2013; Kovács et al., 2002) , and also that adrenomedullary gene expression for enzymes of the catecholamine synthetic pathway are augmented after EtOH consumption (PattersonBuckendahl et al., 2005) . Moreover, Patkar et al. (2004) reported significantly elevated noradrenaline levels in actively drinking humans compared with nondrinking controls. These studies are in line with augmented quantal release of catecholamines, which we found in the CCs of WKY-EtOH and SHR-Control.
Therefore, despite the circulating catecholamine levels are a minor fraction of the amount secreted from sympathetic nerve terminals and plasma catecholamine values may not reflect total sympathetic neural drive and secretion of the neurotransmitter (Grassi et al., 2015) , it seems reasonable to suggest considering all these data and our findings together that the spontaneous hypertension and hypertension elicited by chronic EtOH causes overactivity of the sympathoadrenal axis, representing the pathophysiological background for the hypertension development.
Considering only the absolute elevations of SBP, that is, 14 mmHg in WKY/EtOH and 96 mmHg in SHR/EtOH, with respect to WKY/ Control (Table 1) , this increase is massive. Of course, in the case of SHR/EtOH the baseline SBP at the starting point of EtOH exposure, the baseline value of SBP was already high i.e., 218 mmHg (Table 1) . From these data is seems clear that there is not an obvious relationship between the increased secretory responses of CCs and the blood pressure levels of the four rat groups here studied. We can only say that EtOH exposure causes relative increase of 14 mmHg of SBP in WKY/EtOH and a similar increase in SHR/EtOH, compared with their respective controls and that this is also associated with similar increases in catecholamine release from CCs. We may also guess that the primary event after EtOH exposure is the augmentation of sympathetic drive to the adrenal medulla and that this may be the cause of a greater sensitivity of the secretory machinery to depolarizing stimuli, after chronic EtOH exposure. Such augmented sympathetic drive could have its origin in several of the homeostatic mechanisms linked to EtOH exposure. In addition, for instance, excess production of free radicals associated with EtOH metabolism has been implicated in the elevation of blood pressure and in cardiac hypertrophy. In fact, augmented ALDH activity and of acetaldehyde levels in plasma are present in humans and animals exposed to chronic EtOH consumption [ (Nishimura et al., 2002) ; Table 1 of this article]. It is known that adult SHR rats have a fault in the oxidative metabolism of EtOH and in alcohol dehydrogenase (ADH) enzyme (Rachamin et al., 1980) , as well as increase in plasma levels of H 2 O 2 (Yang et al., 2013) , which cause cardiovascular injury (Movahed et al., 2012 (Hu et al., 2014; Zhang et al., 2004) . Additionally, due to its interaction with hydroxyl or sulfhydryl groups that modify the structure and function of proteins and enzymes, acetaldehyde is known to be around 10 times more toxic than EtOH (Manzo-Avalos and Saavedra-Molina, 2010). Likewise, a human mutation of ALDH and/or its dysfunction leads to oxidative stress that has been associated with increased prevalence of hypertension and myocardial infarction (Amamoto et al., 2002; Takagi et al., 2002) . In this context, we may reasonably guess that enhanced circulating acetaldehyde and ROS in rats exposed to chronic EtOH ( ( Bébarová et al., 2010; Brennan et al., 1989; Mullikin-Kilpatrick and Treistman, 1993) . Also, EtOH itself elicits the release of Ca 2+ from the endoplasmic reticulum of non-excitable cells (Rosado et al., 2006) as well as in cultured neurons from the superior cervical ganglion (Xiao et al., 2005) . Additionally, EtOH accelerates the rate of [Ca 2+ ] c waves associated with ryanodine receptor channels in isolated rat pancreatic acinar cells, an effect that is abolished by dantrolene (Orabi et al., 2011) . Furthermore, H 2 O 2 at 100 µM induces oscillations of [Ca 2+ ] c in human aortic endothelial cells (Hu et al., 1998) . Although the extrapolation of these in vitro data obtained in isolated cells acutely incubated with EtOH or H 2 O 2 to the in vivo experiments could be misleading, the accumulating evidence suggests that in vivo chronic EtOH consumption may elicit multiple alterations in several cell systems including CCs, which are mediated by increased oxidative stress.
The question now arises on how the diminished I Ca of CCs from WKY/EtOH, SHR/Control, and SHR/EtOH, with respect those of WKY/Control (Fig. 1) , could generate higher [Ca 2+ ] c transients. The CCs are known to express L-(Ca v 1.2), N-(Ca v 2.2), and P/Q-(Ca v 2.1) subtypes of Ca v s . These channels undergo Ca 2+ -dependent and time-dependent inactivation, that is faster for N/PQ (Ca v 2.2-2.1) channels in comparison with L-subtype channels (Ca v 1.2), that undergo scarce inactivation (Hernandez-Guijo et al., 2001) . Because the currents were generated by intermittent 50-ms depolarizing pulses and the [Ca 2+ ] c transients were generated by 60-s depolarizing pulses, the comparison of both variables could be tricky. However, it should be considered that smaller I Ca amplitudes were also accompanied by lesser inactivation in CCs from WKY/EtOH, SHR/ Control and SHR/EtOH, with respect to WKY/Control (Figs. 1 and 2) . Although smaller, this non-inactivating current could explain the higher [Ca 2+ ] c transient observed in the three former rat cohorts, compared with the latter WKY/Control.
The augmented Ca 2+ and exocytotic signals in the rats exposed to
EtOH may also find an explanation in the decreased amplitudes of the I k (Fig. 4) that concord with mildly depolarized CCs (Fig. 5E ) and higher number of SAPs in WKY/EtOH, with respect to WKY/Control (Fig. 5F ). Thus, this higher membrane excitability keeps pace with the higher [Ca 2+ ] c and secretion responses of CCs from WKY/EtOH, with respect to WKY/Control. Of interest was that these changes were closely matched in CCs from SHR/Control and SHR/EtOH, indicating that the changes of cell excitability, ion currents, [Ca 2+ ] c transients, and exocytosis were common in rats treated with EtOH and in SHR rats. An interesting outcome from this and other studies is some common pathogenic features of three hypertensive states namely genetic SHR, diabetic (Musial et al., 2015) , and chronic EtOH. As far as the EtOH elicited hypertension, the central topic in this study, the various parameters monitored underwent changes in the same direction to those occurring in SHR/Control and SHR/EtOH. Astonishingly, the WKY/EtOH rats developed hypertension, cardiac hypertrophy, and augmented plasma H 2 O 2 in the same direction than SHR/Control and SHR/EtOH. And even more surprisingly, adrenal CCs of WKY/EtOH underwent phenotypic functional changes (i.e. augmented membrane excitability, [Ca 2+ ] c transients, and catecholamine release, with decreased amplitudes an inactivation of I Ca ), that run in parallel to those underwent by CCs from SHR/Control and SHR/EtOH.
These changes are surely associated with the enhanced activity of the sympathoadrenal axis commonly occurring in genetic hypertension as well as in hypertension elicited by EtOH consumption. In the light of this coincidence, we may raise the hypothesis that enhanced sympathoadrenal activity is a primary pathogenic event in at least three hypertensive clinical sets namely genetic essential hypertension, diabetic hypertension, and hypertension elicited by chronic EtOH consumption. However, further mechanistic studies may be necessary to clarify the alterations in CCs elicited by chronic EtOH consumption.
Conclusions
In conclusion, the results here reported suggest that the hypertension elicited by chronic EtOH has pathogenic features common to genetic hypertension namely, a drastic increase of [Ca 2+ ] c transients and catecholamine release in their adrenal medullary CCs. 
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